Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.002 | 0.5856 | 0.5761 |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.0223 | 0.0381 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.5856 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.1911 | 0.1727 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.002 | 0.5856 | 0.4877 |
Echinococcus multilocularis | bloom syndrome protein | 0.002 | 0.5856 | 0.4877 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 0.5856 | 0.5 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.5856 | 0.4291 |
Echinococcus granulosus | lamin | 0.0027 | 1 | 1 |
Echinococcus multilocularis | lamin | 0.0027 | 1 | 1 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.002 | 0.5856 | 0.4877 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.002 | 0.5856 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0027 | 1 | 1 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.002 | 0.5856 | 0.4877 |
Schistosoma mansoni | lamin | 0.0027 | 1 | 1 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.0223 | 1 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.5856 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.5856 | 0.5761 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.5856 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0027 | 1 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.002 | 0.5856 | 0.4877 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 1 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0027 | 1 | 1 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.002 | 0.5856 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.1625 | 0.1434 |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.002 | 0.5856 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.1625 | 0.1434 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.9714 | 0.9707 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0223 | 0.0381 |
Echinococcus granulosus | bloom syndrome protein | 0.002 | 0.5856 | 0.4877 |
Onchocerca volvulus | 0.0027 | 1 | 0.5 | |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.0223 | 0.0223 |
Schistosoma mansoni | DNA helicase recq5 | 0.002 | 0.5856 | 0.5856 |
Entamoeba histolytica | recQ family helicase, putative | 0.002 | 0.5856 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 1 | 1 |
Echinococcus multilocularis | musashi | 0.0027 | 1 | 1 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.5856 | 0.4291 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.2742 | 0.2576 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.5856 | 0.5 |
Schistosoma mansoni | DNA helicase recq1 | 0.002 | 0.5856 | 0.5856 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0223 | 0.0000000048454 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.002 | 0.5856 | 0.5 |
Brugia malayi | Bloom's syndrome protein homolog | 0.002 | 0.5856 | 0.4291 |
Loa Loa (eye worm) | RecQ helicase | 0.002 | 0.5856 | 0.5761 |
Onchocerca volvulus | 0.0027 | 1 | 0.5 | |
Schistosoma mansoni | lamin | 0.0027 | 1 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.5856 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 1 | 1 |
Treponema pallidum | ATP-dependent DNA helicase | 0.001 | 0.0223 | 0.5 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 0.5856 | 0.5 |
Echinococcus multilocularis | lamin dm0 | 0.0027 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.